Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Dec 6;91(25):11958–11962. doi: 10.1073/pnas.91.25.11958

An ADP-ribosyltransferase as a potential target for nitric oxide action in hippocampal long-term potentiation.

E M Schuman 1, M K Meffert 1, H Schulman 1, D V Madison 1
PMCID: PMC45355  PMID: 7991564

Abstract

Recent studies of long-term potentiation (LTP) in the CA1 region of the hippocampus have demonstrated that nitric oxide (NO) may be involved in some forms of LTP and have suggested that postsynaptically generated NO is a candidate to act as a retrograde messenger. However, the molecular target(s) of NO in LTP remain to be elucidated. The present study examined whether either of two potential NO targets, a soluble guanylyl cyclase or an ADP-ribosyltransferase (ADPRT; EC 2.4.2.31) plays a role in LTP. The application of membrane-permeant analogs of cGMP did not produce any long-lasting alterations in synaptic strength. In addition, application of a cGMP-dependent protein kinase inhibitor did not prevent LTP. We found that the CA1 tissue from hippocampus possesses an ADPRT activity that is dramatically stimulated by NO and attenuated by two different inhibitors of mono-ADPRT activity, phylloquinone and nicotinamide. The extracellular application of these same inhibitors prevented LTP. Postsynaptic injection of nicotinamide failed to attenuate LTP, suggesting that the critical site of ADPRT activity resides at a nonpostsynaptic locus. These results suggest that ADP-ribosylation plays a role in LTP and are consistent with the idea that an ADPRT may be a target of NO action.

Full text

PDF
11958

Images in this article

11961Image
on p.11961

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aktories K., Hall A. Botulinum ADP-ribosyltransferase C3: a new tool to study low molecular weight GTP-binding proteins. Trends Pharmacol Sci. 1989 Oct;10(10):415–418. doi: 10.1016/0165-6147(89)90191-0. [DOI] [PubMed] [Google Scholar]
  2. Banasik M., Komura H., Shimoyama M., Ueda K. Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase. J Biol Chem. 1992 Jan 25;267(3):1569–1575. [PubMed] [Google Scholar]
  3. Bliss T. V., Collingridge G. L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993 Jan 7;361(6407):31–39. doi: 10.1038/361031a0. [DOI] [PubMed] [Google Scholar]
  4. Bliss T. V., Douglas R. M., Errington M. L., Lynch M. A. Correlation between long-term potentiation and release of endogenous amino acids from dentate gyrus of anaesthetized rats. J Physiol. 1986 Aug;377:391–408. doi: 10.1113/jphysiol.1986.sp016193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A. 1989 Nov;86(22):9030–9033. doi: 10.1073/pnas.86.22.9030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brüne B., Lapetina E. G. Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J Biol Chem. 1989 May 25;264(15):8455–8458. [PubMed] [Google Scholar]
  7. Brüne B., Lapetina E. G. Properties of a novel nitric oxide-stimulated ADP-ribosyltransferase. Arch Biochem Biophys. 1990 Jun;279(2):286–290. doi: 10.1016/0003-9861(90)90493-i. [DOI] [PubMed] [Google Scholar]
  8. Böhme G. A., Bon C., Stutzmann J. M., Doble A., Blanchard J. C. Possible involvement of nitric oxide in long-term potentiation. Eur J Pharmacol. 1991 Jul 9;199(3):379–381. doi: 10.1016/0014-2999(91)90505-k. [DOI] [PubMed] [Google Scholar]
  9. Chetkovich D. M., Klann E., Sweatt J. D. Nitric oxide synthase-independent long-term potentiation in area CA1 of hippocampus. Neuroreport. 1993 Jul;4(7):919–922. doi: 10.1097/00001756-199307000-00020. [DOI] [PubMed] [Google Scholar]
  10. Coggins P. J., McLean K., Nagy A., Zwiers H. ADP-ribosylation of the neuronal phosphoprotein B-50/GAP-43. J Neurochem. 1993 Jan;60(1):368–371. doi: 10.1111/j.1471-4159.1993.tb05862.x. [DOI] [PubMed] [Google Scholar]
  11. Dekker L. V., De Graan P. N., Oestreicher A. B., Versteeg D. H., Gispen W. H. Inhibition of noradrenaline release by antibodies to B-50 (GAP-43). Nature. 1989 Nov 2;342(6245):74–76. doi: 10.1038/342074a0. [DOI] [PubMed] [Google Scholar]
  12. Dimmeler S., Lottspeich F., Brüne B. Nitric oxide causes ADP-ribosylation and inhibition of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem. 1992 Aug 25;267(24):16771–16774. [PubMed] [Google Scholar]
  13. Duman R. S., Terwilliger R. Z., Nestler E. J. Alterations in nitric oxide-stimulated endogenous ADP-ribosylation associated with long-term potentiation in rat hippocampus. J Neurochem. 1993 Oct;61(4):1542–1545. doi: 10.1111/j.1471-4159.1993.tb13652.x. [DOI] [PubMed] [Google Scholar]
  14. Duman R. S., Terwilliger R. Z., Nestler E. J. Endogenous ADP-ribosylation in brain: initial characterization of substrate proteins. J Neurochem. 1991 Dec;57(6):2124–2132. doi: 10.1111/j.1471-4159.1991.tb06431.x. [DOI] [PubMed] [Google Scholar]
  15. Ehret-Hilberer S., Nullans G., Aunis D., Virmaux N. Mono ADP-ribosylation of transducin catalyzed by rod outer segment extract. FEBS Lett. 1992 Sep 14;309(3):394–398. doi: 10.1016/0014-5793(92)80814-w. [DOI] [PubMed] [Google Scholar]
  16. Fischer von Mollard G., Südhof T. C., Jahn R. A small GTP-binding protein dissociates from synaptic vesicles during exocytosis. Nature. 1991 Jan 3;349(6304):79–81. doi: 10.1038/349079a0. [DOI] [PubMed] [Google Scholar]
  17. Gally J. A., Montague P. R., Reeke G. N., Jr, Edelman G. M. The NO hypothesis: possible effects of a short-lived, rapidly diffusible signal in the development and function of the nervous system. Proc Natl Acad Sci U S A. 1990 May;87(9):3547–3551. doi: 10.1073/pnas.87.9.3547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Garthwaite J., Charles S. L., Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 1988 Nov 24;336(6197):385–388. doi: 10.1038/336385a0. [DOI] [PubMed] [Google Scholar]
  19. Gribkoff V. K., Lum-Ragan J. T. Evidence for nitric oxide synthase inhibitor-sensitive and insensitive hippocampal synaptic potentiation. J Neurophysiol. 1992 Aug;68(2):639–642. doi: 10.1152/jn.1992.68.2.639. [DOI] [PubMed] [Google Scholar]
  20. Haley J. E., Malen P. L., Chapman P. F. Nitric oxide synthase inhibitors block long-term potentiation induced by weak but not strong tetanic stimulation at physiological brain temperatures in rat hippocampal slices. Neurosci Lett. 1993 Sep 17;160(1):85–88. doi: 10.1016/0304-3940(93)90919-c. [DOI] [PubMed] [Google Scholar]
  21. Haley J. E., Wilcox G. L., Chapman P. F. The role of nitric oxide in hippocampal long-term potentiation. Neuron. 1992 Feb;8(2):211–216. doi: 10.1016/0896-6273(92)90288-o. [DOI] [PubMed] [Google Scholar]
  22. Hidaka H., Inagaki M., Kawamoto S., Sasaki Y. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry. 1984 Oct 9;23(21):5036–5041. doi: 10.1021/bi00316a032. [DOI] [PubMed] [Google Scholar]
  23. Izumi Y., Clifford D. B., Zorumski C. F. Inhibition of long-term potentiation by NMDA-mediated nitric oxide release. Science. 1992 Aug 28;257(5074):1273–1276. doi: 10.1126/science.1519065. [DOI] [PubMed] [Google Scholar]
  24. Jacobson M. K., Loflin P. T., Aboul-Ela N., Mingmuang M., Moss J., Jobson E. L. Modification of plasma membrane protein cysteine residues by ADP-ribose in vivo. J Biol Chem. 1990 Jul 5;265(19):10825–10828. [PubMed] [Google Scholar]
  25. Knowles R. G., Palacios M., Palmer R. M., Moncada S. Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5159–5162. doi: 10.1073/pnas.86.13.5159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kots AYa, Skurat A. V., Sergienko E. A., Bulargina T. V., Severin E. S. Nitroprusside stimulates the cysteine-specific mono(ADP-ribosylation) of glyceraldehyde-3-phosphate dehydrogenase from human erythrocytes. FEBS Lett. 1992 Mar 23;300(1):9–12. doi: 10.1016/0014-5793(92)80153-8. [DOI] [PubMed] [Google Scholar]
  27. Matsuyama S., Tsuyama S. Mono-ADP-ribosylation in brain: purification and characterization of ADP-ribosyltransferases affecting actin from rat brain. J Neurochem. 1991 Oct;57(4):1380–1387. doi: 10.1111/j.1471-4159.1991.tb08304.x. [DOI] [PubMed] [Google Scholar]
  28. McDonald L. J., Wainschel L. A., Oppenheimer N. J., Moss J. Amino acid-specific ADP-ribosylation: structural characterization and chemical differentiation of ADP-ribose-cysteine adducts formed nonenzymatically and in a pertussis toxin-catalyzed reaction. Biochemistry. 1992 Dec 1;31(47):11881–11887. doi: 10.1021/bi00162a029. [DOI] [PubMed] [Google Scholar]
  29. Meffert M. K., Premack B. A., Schulman H. Nitric oxide stimulates Ca(2+)-independent synaptic vesicle release. Neuron. 1994 Jun;12(6):1235–1244. doi: 10.1016/0896-6273(94)90440-5. [DOI] [PubMed] [Google Scholar]
  30. Molina y Vedia L., McDonald B., Reep B., Brüne B., Di Silvio M., Billiar T. R., Lapetina E. G. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP-ribosylation. J Biol Chem. 1992 Dec 15;267(35):24929–24932. [PubMed] [Google Scholar]
  31. Montague P. R., Gancayco C. D., Winn M. J., Marchase R. B., Friedlander M. J. Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science. 1994 Feb 18;263(5149):973–977. doi: 10.1126/science.7508638. [DOI] [PubMed] [Google Scholar]
  32. Moss J., Stanley S. J., Watkins P. A. Isolation and properties of an NAD- and guanidine-dependent ADP-ribosyltransferase from turkey erythrocytes. J Biol Chem. 1980 Jun 25;255(12):5838–5840. [PubMed] [Google Scholar]
  33. Moss J., Vaughan M. Isolation of an avian erythrocyte protein possessing ADP-ribosyltransferase activity and capable of activating adenylate cyclase. Proc Natl Acad Sci U S A. 1978 Aug;75(8):3621–3624. doi: 10.1073/pnas.75.8.3621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Murad F., Mittal C. K., Arnold W. P., Katsuki S., Kimura H. Guanylate cyclase: activation by azide, nitro compounds, nitric oxide, and hydroxyl radical and inhibition by hemoglobin and myoglobin. Adv Cyclic Nucleotide Res. 1978;9:145–158. [PubMed] [Google Scholar]
  35. Musleh W. Y., Shahi K., Baudry M. Further studies concerning the role of nitric oxide in LTP induction and maintenance. Synapse. 1993 Apr;13(4):370–375. doi: 10.1002/syn.890130409. [DOI] [PubMed] [Google Scholar]
  36. Mülsch A., Busse R., Liebau S., Förstermann U. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J Pharmacol Exp Ther. 1988 Oct;247(1):283–288. [PubMed] [Google Scholar]
  37. O'Dell T. J., Hawkins R. D., Kandel E. R., Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11285–11289. doi: 10.1073/pnas.88.24.11285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Pancholi V., Fischetti V. A. Glyceraldehyde-3-phosphate dehydrogenase on the surface of group A streptococci is also an ADP-ribosylating enzyme. Proc Natl Acad Sci U S A. 1993 Sep 1;90(17):8154–8158. doi: 10.1073/pnas.90.17.8154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pozdnyakov N., Lloyd A., Reddy V. N., Sitaramayya A. Nitric oxide-regulated endogenous ADP-ribosylation of rod outer segment proteins. Biochem Biophys Res Commun. 1993 Apr 30;192(2):610–615. doi: 10.1006/bbrc.1993.1459. [DOI] [PubMed] [Google Scholar]
  40. Rankin P. W., Jacobson E. L., Benjamin R. C., Moss J., Jacobson M. K. Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. J Biol Chem. 1989 Mar 15;264(8):4312–4317. [PubMed] [Google Scholar]
  41. Schuman E. M., Madison D. V. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science. 1991 Dec 6;254(5037):1503–1506. doi: 10.1126/science.1720572. [DOI] [PubMed] [Google Scholar]
  42. Schuman E. M., Madison D. V. Locally distributed synaptic potentiation in the hippocampus. Science. 1994 Jan 28;263(5146):532–536. doi: 10.1126/science.8290963. [DOI] [PubMed] [Google Scholar]
  43. Tanuma S., Kawashima K., Endo H. Eukaryotic mono(ADP-ribosyl)transferase that ADP-ribosylates GTP-binding regulatory Gi protein. J Biol Chem. 1988 Apr 15;263(11):5485–5489. [PubMed] [Google Scholar]
  44. Ueda K., Hayaishi O. ADP-ribosylation. Annu Rev Biochem. 1985;54:73–100. doi: 10.1146/annurev.bi.54.070185.000445. [DOI] [PubMed] [Google Scholar]
  45. Williams J. H., Li Y. G., Nayak A., Errington M. L., Murphy K. P., Bliss T. V. The suppression of long-term potentiation in rat hippocampus by inhibitors of nitric oxide synthase is temperature and age dependent. Neuron. 1993 Nov;11(5):877–884. doi: 10.1016/0896-6273(93)90117-a. [DOI] [PubMed] [Google Scholar]
  46. Williams M. B., Li X., Gu X., Jope R. S. Modulation of endogenous ADP-ribosylation in rat brain. Brain Res. 1992 Oct 2;592(1-2):49–56. doi: 10.1016/0006-8993(92)91657-z. [DOI] [PubMed] [Google Scholar]
  47. Zhang J., Dawson V. L., Dawson T. M., Snyder S. H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 1994 Feb 4;263(5147):687–689. doi: 10.1126/science.8080500. [DOI] [PubMed] [Google Scholar]
  48. Zhang J., Snyder S. H. Nitric oxide stimulates auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A. 1992 Oct 15;89(20):9382–9385. doi: 10.1073/pnas.89.20.9382. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Zhuo M., Hu Y., Schultz C., Kandel E. R., Hawkins R. D. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature. 1994 Apr 14;368(6472):635–639. doi: 10.1038/368635a0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES